Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renzo Mignani

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Biomedicines|April 29, 2025
The Role of Kidney Biopsy in Fabry DiseaseIrene Capelli, Laura Martano, Gian Marco Berti, et al.
Renal Failure|February 4, 2025
Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experienceYuri Battaglia, Federica Baciga, Meilad Shakkour, et al.
Circulation. Cardiovascular Imaging|April 5, 2019
Predictors of Clinical Evolution in Prehypertrophic Fabry DiseaseAntonia Camporeale, Maurizio Pieroni, Federico Pieruzzi, et al.
International Journal of Cardiology|July 18, 2021
ECG-based score estimates the probability to detect Fabry Disease cardiac involvementStefano Figliozzi, Antonia Camporeale, Sara Boveri, et al.
Plos One|July 4, 2017
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathyRocco Liguori, Alex Incensi, Silvia de Pasqua, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 4, 2010
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry RegistryChristoph Wanner, João P Oliveira, Alberto Ortiz, et al.
Clinical Chemistry and Laboratory Medicine|April 29, 2021
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patientsSabrina Malvagia, Lorenzo Ferri, Maria Della Bona, et al.
European Heart Journal. Cardiovascular Imaging|January 24, 2021
Trabecular complexity as an early marker of cardiac involvement in Fabry diseaseAntonia Camporeale, Francesco Moroni, Davide Lazzeroni, et al.
Scientific Reports|January 12, 2026
Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathyGiorgio Cazzaniga, Maurizio Carbone, Raffaella Barretta, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Biomedicines|April 29, 2025
The Role of Kidney Biopsy in Fabry DiseaseIrene Capelli, Laura Martano, Gian Marco Berti, et al.
Renal Failure|February 4, 2025
Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experienceYuri Battaglia, Federica Baciga, Meilad Shakkour, et al.
Circulation. Cardiovascular Imaging|April 5, 2019
Predictors of Clinical Evolution in Prehypertrophic Fabry DiseaseAntonia Camporeale, Maurizio Pieroni, Federico Pieruzzi, et al.
International Journal of Cardiology|July 18, 2021
ECG-based score estimates the probability to detect Fabry Disease cardiac involvementStefano Figliozzi, Antonia Camporeale, Sara Boveri, et al.
Plos One|July 4, 2017
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathyRocco Liguori, Alex Incensi, Silvia de Pasqua, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 4, 2010
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry RegistryChristoph Wanner, João P Oliveira, Alberto Ortiz, et al.
Clinical Chemistry and Laboratory Medicine|April 29, 2021
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patientsSabrina Malvagia, Lorenzo Ferri, Maria Della Bona, et al.
European Heart Journal. Cardiovascular Imaging|January 24, 2021
Trabecular complexity as an early marker of cardiac involvement in Fabry diseaseAntonia Camporeale, Francesco Moroni, Davide Lazzeroni, et al.
Scientific Reports|January 12, 2026
Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathyGiorgio Cazzaniga, Maurizio Carbone, Raffaella Barretta, et al.
Pageof 7